SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-025650
Filing Date
2023-02-27
Accepted
2023-02-27 07:58:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm237768d1_424b5.htm 424B5 338844
2 GRAPHIC image_001.jpg GRAPHIC 5272
3 GRAPHIC tm2212977d1_s3sp1.jpg GRAPHIC 11565
4 GRAPHIC tm2121220d1_424b5img002.jpg GRAPHIC 41847
  Complete submission text file 0001104659-23-025650.txt   421312
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264394 | Film No.: 23670087
SIC: 2836 Biological Products, (No Diagnostic Substances)